Press "Enter" to skip to content

New patent for Astrazeneca drug TUDORZA PRESSAIR

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug TUDORZA PRESSAIR

Annual Drug Patent Expirations for TUDORZA+PRESSAIR
Annual Drug Patent Expirations for TUDORZA+PRESSAIR

Tudorza Pressair is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has one hundred and twenty-seven patent family members in forty-three countries.

The generic ingredient in TUDORZA PRESSAIR is aclidinium bromide. One supplier is listed for this compound. Additional details are available on the aclidinium bromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug TUDORZA PRESSAIR
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions